Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2005 | 06-2005 | 03-2005 | 12-2004 | 09-2004 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 959,000 | 1,276,000 | 1,476,000 | 1,808,000 | 1,864,000 |
| Marketable Securities | 12,430,000 | 13,293,000 | 20,495,000 | 18,085,000 | 16,814,000 |
| Receivables | 9,348,000 | 9,316,000 | 10,074,000 | 9,367,000 | 9,216,000 |
| Inventories | 6,556,000 | 6,480,000 | 6,551,000 | 6,660,000 | 6,295,000 |
| Other current assets | 751,000 | 702,000 | 965,000 | 835,000 | 910,000 |
| TOTAL | $32,768,000 | $33,573,000 | $42,353,000 | $39,088,000 | $39,057,000 |
| Non-Current Assets | |||||
| PPE Net | 17,519,000 | 17,673,000 | 17,912,000 | 18,385,000 | 17,477,000 |
| Investments And Advances | 2,784,000 | 3,247,000 | 3,619,000 | 3,873,000 | 4,216,000 |
| Intangibles | 52,782,000 | 53,409,000 | 54,672,000 | 57,007,000 | 56,676,000 |
| Other Non-Current Assets | 4,490,000 | 4,425,000 | 4,379,000 | 4,725,000 | 4,803,000 |
| TOTAL | $77,575,000 | $78,754,000 | $80,582,000 | $83,990,000 | $83,172,000 |
| Total Assets | $110,343,000 | $112,327,000 | $122,935,000 | $123,078,000 | $122,229,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 6,729,000 | 7,261,000 | 13,399,000 | 11,266,000 | 10,858,000 |
| Accounts payable and accrued liabilities | 1,809,000 | 2,100,000 | 2,300,000 | 2,672,000 | 2,329,000 |
| Accrued Expenses | 1,636,000 | 1,469,000 | 1,601,000 | 1,939,000 | 1,835,000 |
| Other current liabilities | 5,992,000 | 5,974,000 | 6,357,000 | 7,200,000 | 6,249,000 |
| TOTAL | $20,395,000 | $22,566,000 | $28,948,000 | $26,458,000 | $25,239,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,414,000 | 5,517,000 | 6,432,000 | 7,279,000 | 7,956,000 |
| Other Non-Current Liabilities | 6,947,000 | 7,437,000 | 7,286,000 | 9,037,000 | 8,689,000 |
| TOTAL | $23,141,000 | $24,433,000 | $26,455,000 | $28,342,000 | $28,607,000 |
| Total Liabilities | $43,536,000 | $46,999,000 | $55,403,000 | $54,800,000 | $53,846,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 7,371,397 | 7,370,501 | 7,435,344 | 7,458,874 | 7,530,995 |
| Common Shares | 439,000 | 439,000 | 438,000 | 438,000 | 437,000 |
| Retained earnings | 38,033,000 | 36,446,000 | 35,785,000 | 35,492,000 | 35,347,000 |
| Other shareholders' equity | 190,000 | 289,000 | 1,094,000 | 1,242,000 | -339,000 |
| TOTAL | $66,807,000 | $65,328,000 | $67,532,000 | $68,278,000 | $68,383,000 |
| Total Liabilities And Equity | $110,343,000 | $112,327,000 | $122,935,000 | $123,078,000 | $122,229,000 |